- Home
- AXSM vs ALLE Comparison
AXSM vs ALLE Comparison
Compare AXSM & ALLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | ALLE |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 11.2B |
| IPO Year | 2015 | 2013 |
Fundamental Metrics
Financial Performance| Metric | AXSM | ALLE |
|---|---|---|
| Price | $251.46 | $129.85 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 17 | 8 |
| Target Price | ★ $211.12 | $167.13 |
| AVG Volume (30 Days) | 592.3K | ★ 801.3K |
| Earning Date | 05-04-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.60% |
| EPS Growth | ★ 38.56 | 9.09 |
| EPS | N/A | ★ 1.59 |
| Revenue | N/A | N/A |
| Revenue This Year | $57.24 | $8.47 |
| Revenue Next Year | $55.88 | $4.58 |
| P/E Ratio | ★ N/A | $84.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $96.09 | $125.00 |
| 52 Week High | $257.93 | $183.11 |
Technical Indicators
Market Signals| Indicator | AXSM | ALLE |
|---|---|---|
| Relative Strength Index (RSI) | 70.07 | 44.74 |
| Support Level | $148.87 | $125.93 |
| Resistance Level | N/A | $133.60 |
| Average True Range (ATR) | 8.48 | 3.23 |
| MACD | 0.46 | 0.69 |
| Stochastic Oscillator | 84.87 | 32.36 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.